Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Klein

Showing results (1191-1200 of 1,374) with videos related to

Pageof 138
Sort By:
HIV Medicine|May 30, 2012
HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortalityM B Klein, K C Rollet, S Saeed, et al.
Oncogene|September 1, 2009
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesisA Seckinger, T Meissner, J Moreaux, et al.
The Lancet. Public Health|March 25, 2023
Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort studyCas J Isfordink, Anders Boyd, Rachel Sacks-Davis, et al.
Transplantation|March 15, 1997
Safety and tolerability of cyclosporine microemulsion versus cyclosporine: two-year data in primary renal allograft recipients: a report of the Neoral Study GroupM D Pescovitz, G Barone, M G Choc, et al.
Scientific Reports|April 15, 2024
Non-invasive biomarkers for detecting progression toward hypovolemic cardiovascular instability in a lower body negative pressure modelEthan K Murphy, Spencer R Bertsch, Samuel B Klein, et al.
Gastro Hep Advances|May 25, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIVFelice Cinque, Michael Nudo, Sahar Saeed, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 25, 2010
A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppressionMona R Loutfy, Miguel Genebat, David Moore, et al.
The Lancet. HIV|January 27, 2019
Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studiesKeri N Althoff, Kelly A Gebo, Richard D Moore, et al.
Transplantation|March 27, 1996
The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary renal allograft recipients. The Neoral Study GroupG Barone, C M Bunke, M G Choc, et al.
Scientific Reports|July 11, 2025
Defining subgroups of pediatric nephrotic patients with urine proteomicsTimothy D Cummins, Laura H Mariani, Daniel W Wilkey, et al.
Pageof 138

Showing results (1191-1200 of 1,374) with videos related to

Sort By:
Pageof 138
HIV Medicine|May 30, 2012
HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortalityM B Klein, K C Rollet, S Saeed, et al.
Oncogene|September 1, 2009
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesisA Seckinger, T Meissner, J Moreaux, et al.
The Lancet. Public Health|March 25, 2023
Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort studyCas J Isfordink, Anders Boyd, Rachel Sacks-Davis, et al.
Transplantation|March 15, 1997
Safety and tolerability of cyclosporine microemulsion versus cyclosporine: two-year data in primary renal allograft recipients: a report of the Neoral Study GroupM D Pescovitz, G Barone, M G Choc, et al.
Scientific Reports|April 15, 2024
Non-invasive biomarkers for detecting progression toward hypovolemic cardiovascular instability in a lower body negative pressure modelEthan K Murphy, Spencer R Bertsch, Samuel B Klein, et al.
Gastro Hep Advances|May 25, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIVFelice Cinque, Michael Nudo, Sahar Saeed, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 25, 2010
A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppressionMona R Loutfy, Miguel Genebat, David Moore, et al.
The Lancet. HIV|January 27, 2019
Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studiesKeri N Althoff, Kelly A Gebo, Richard D Moore, et al.
Transplantation|March 27, 1996
The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary renal allograft recipients. The Neoral Study GroupG Barone, C M Bunke, M G Choc, et al.
Scientific Reports|July 11, 2025
Defining subgroups of pediatric nephrotic patients with urine proteomicsTimothy D Cummins, Laura H Mariani, Daniel W Wilkey, et al.
Pageof 138